cetrimonium bromide has been researched along with sch-202676 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Attene-Ramos, M; Baker, HL; Burkart, MD; Daniel, T; Foley, TL; Jadhav, A; Kosa, NM; Leister, W; Maloney, DJ; Rai, G; Simeonov, A; Yasgar, A | 1 |
1 other study(ies) available for cetrimonium bromide and sch-202676
Article | Year |
---|---|
4-(3-Chloro-5-(trifluoromethyl)pyridin-2-yl)-N-(4-methoxypyridin-2-yl)piperazine-1-carbothioamide (ML267), a potent inhibitor of bacterial phosphopantetheinyl transferase that attenuates secondary metabolism and thwarts bacterial growth.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Dipeptides; Drug Resistance, Bacterial; Drug Synergism; Escherichia coli; Gram-Positive Bacteria; Humans; Male; Mice; Microbial Sensitivity Tests; Microsomes, Liver; Pyridines; Secondary Metabolism; Structure-Activity Relationship; Thiourea; Transferases (Other Substituted Phosphate Groups) | 2014 |